An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter

被引:306
|
作者
Cleutjens, KBJM
vanderKorput, HAGM
vanEekelen, CCEM
vanRooij, HCJ
Faber, PW
Trapman, J
机构
关键词
D O I
10.1210/me.11.2.148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prostate-specific antigen (PSA) is expressed at a high level in the luminal epithelial cells of the prostate and is absent or expressed at very low levels in other tissues. PSA expression can be regulated by androgens. Previously, two functional androgen-response elements were identified in the proximal promoter of the PsA gene. To detect additional, more distal control elements, DNaseI-hypersensitive sites (DHSs) upstream of the PSA gene were mapped in chromatin from the prostate-derived cell line LNCaP grown in the presence and absence of the synthetic androgen R1881. In a region 4.8 to 3.8 kb upstream of the transcription start site of the PSA gene, a cluster of three DHSs was detected. The middle DNAseI-hypersensitive site (DHSII, at similar to-4.2 kb) showed strong androgen responsiveness in LNCaP cells and was absent in chromatin from HeLa cells. Further analysis of the region encompassing DHSII provided evidence for the presence of a complex, androgen-responsive and cell-specific enhancer. In transient transfected LNCaP cells, PSA promoter constructs containing this upstream enhancer region showed approximately 3000-fold higher activity in the presence than in the absence of R1881. The core region of the enhancer could be mapped within a 440-bp fragment. The enhancer showed synergistic cooperation with the proximal PsA promoter and was found to be composed of at least three separate regulatory regions. In the center, a functionally active, high-affinity androgen receptor binding site (GGAACATATTGTATC) could be identified. Mutation of this element almost completely abolished PSA promoter activity. Transfection experiments in prostate and nonprostate cell lines showed largely LNCaP cell specificity of the upstream enhancer region, although some activity was found in the T47D mammary tumor cell line.
引用
收藏
页码:148 / 161
页数:14
相关论文
共 50 条
  • [31] Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter
    Bharaj, B
    Scorilas, A
    Diamandis, EP
    Giai, M
    Levesque, MA
    Sutherland, DJA
    Hoffman, BR
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 61 (02) : 111 - 119
  • [32] Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter
    Bhupinder Bharaj
    Andreas Scorilas
    Eleftherios P. Diamandis
    Maurizia Giai
    Michael A. Levesque
    Donald J.A. Sutherland
    Barry R. Hoffman
    Breast Cancer Research and Treatment, 2000, 61 : 111 - 119
  • [33] Breast tissues in transsexual women - A nonprostatic source of androgen up-regulated production of prostate-specific antigen
    Goh, VHH
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (09): : 3313 - 3315
  • [34] Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 genes
    Sun, ZJ
    Pan, J
    Balk, SP
    NUCLEIC ACIDS RESEARCH, 1997, 25 (16) : 3318 - 3325
  • [35] In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: A potential alternative approach to androgen deprivation therapy
    Uchida, A
    O'Keefe, DS
    Bacich, DJ
    Molloy, PL
    Heston, WDW
    UROLOGY, 2001, 58 (2A) : 132 - 139
  • [36] C/EBPα and C/EBPβ repress the prostate specific antigen (PSA) promoter by competing with the androgen receptor for binding to androgen response elements.
    Said, SM
    Hentschel, DM
    Bonventre, JV
    Hsu, SI
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 505A - 505A
  • [37] Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines
    Spitzweg, C
    Zhang, SB
    Bergert, ER
    Castro, MR
    McIver, B
    Heufelder, AE
    Tindall, DJ
    Young, CYF
    Morris, JC
    CANCER RESEARCH, 1999, 59 (09) : 2136 - 2141
  • [38] Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation
    Niu, Yuanjie
    Yeh, Shuyuan
    Miyamoto, Hiroshi
    Li, Gonghui
    Altuwaijri, Saleh
    Yuan, Jianqun
    Han, Ruifa
    Ma, Tengxiang
    Kuo, Hann-Chorng
    Chang, Chawnshang
    CANCER RESEARCH, 2008, 68 (17) : 7110 - 7119
  • [39] Prostate-specific Antigen Kinetics During Androgen-deprivation Therapy Predict Response to Enzalutamide in Metastatic Castration-resistant Prostate Cancer
    Nagata, Yujiro
    Matsukawa, Takuo
    Tomisaki, Ikko
    Fujimoto, Naohiro
    ANTICANCER RESEARCH, 2023, 43 (01) : 429 - 436
  • [40] RAPID, DURABLE, AND DEEP PROSTATE-SPECIFIC ANTIGEN RESPONSE FOLLOWING ADDITION OF DAROLUTAMIDE TO ANDROGEN-DEPRIVATION THERAPY AND DOCETAXEL IN ARASENS
    Saad, Fred
    Tombal, Bertrand
    Hussain, Maha
    Fizazi, Karim
    Sternberg, Cora N.
    Crawford, E. David
    Nordquist, Luke T.
    Tutrone, Ronald
    Shore, Neal D.
    Belkoff, Laurence
    Kapur, Shivani
    Jhaveri, Jay
    Ortiz, Jorge
    Srinivasan, Shankar
    Verholen, Frank
    Smith, Matthew R.
    JOURNAL OF UROLOGY, 2023, 209 : E380 - E380